Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity.

Gudmundsson G, Gislason T, Lindberg E, Hallin R, Ulrik CS, Brøndum E, Nieminen MM, Aine T, Bakke P, Janson C.

Respir Res. 2006 Aug 16;7:109.

2.

Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries.

Gudmundsson G, Ulrik CS, Gislason T, Lindberg E, Brøndum E, Bakke P, Janson C.

Int J Chron Obstruct Pulmon Dis. 2012;7:571-6. doi: 10.2147/COPD.S34466.

3.

Predictors of 6-month mortality in elderly patients with mild chronic obstructive pulmonary disease discharged from a medical ward after acute nonacidotic exacerbation.

Ranieri P, Bianchetti A, Margiotta A, Virgillo A, Clini EM, Trabucchi M.

J Am Geriatr Soc. 2008 May;56(5):909-13. doi: 10.1111/j.1532-5415.2008.01683.x.

PMID:
18384582
4.

Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.

Gershon AS, Wang L, To T, Luo J, Upshur RE.

COPD. 2008 Aug;5(4):229-34. doi: 10.1080/15412550802237507.

PMID:
18671148
5.

Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression.

Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, Brøndum E, Nieminen MM, Aine T, Bakke P.

Eur Respir J. 2005 Sep;26(3):414-9.

6.

Adherence to treatment guidelines and long-term survival in hospitalized patients with chronic obstructive pulmonary disease.

Sarc I, Jeric T, Ziherl K, Suskovic S, Kosnik M, Anker SD, Lainscak M.

J Eval Clin Pract. 2011 Aug;17(4):737-43. doi: 10.1111/j.1365-2753.2010.01617.x.

PMID:
21223458
7.

Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease.

Antonelli Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, Pistelli R.

Eur Respir J. 1997 Dec;10(12):2794-800.

8.

Clinical characteristics associated with adverse events in patients with exacerbation of chronic obstructive pulmonary disease: a prospective cohort study.

Stiell IG, Clement CM, Aaron SD, Rowe BH, Perry JJ, Brison RJ, Calder LA, Lang E, Borgundvaag B, Forster AJ, Wells GA.

CMAJ. 2014 Apr 1;186(6):E193-204. doi: 10.1503/cmaj.130968.

9.
10.

Incidence and risk factors of exacerbations among COPD patients in primary health care: APMPOC study.

Borrell E, Rodríguez M, Torán P, Muñoz L, Pera G, Montellà N, Monteagudo M, Urrea M, Puigfel Y, Negrete A, Mezquiriz X, Domènech C, Lacasta A, García ML, Maneus S, Tintoré G.

BMC Public Health. 2009 Jan 9;9:8. doi: 10.1186/1471-2458-9-8.

11.

Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease.

Lee TA, Pickard AS, Au DH, Bartle B, Weiss KB.

Ann Intern Med. 2008 Sep 16;149(6):380-90.

PMID:
18794557
12.

The TORCH (towards a revolution in COPD health) survival study protocol.

Vestbo J; TORCH Study Group..

Eur Respir J. 2004 Aug;24(2):206-10.

13.

Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease.

Almagro P, Salvadó M, Garcia-Vidal C, Rodríguez-Carballeira M, Cuchi E, Torres J, Heredia JL.

Respiration. 2012;84(1):36-43. doi: 10.1159/000331224.

PMID:
21996555
14.

Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD).

Hallin R, Gudmundsson G, Suppli Ulrik C, Nieminen MM, Gislason T, Lindberg E, Brøndum E, Aine T, Bakke P, Janson C.

Respir Med. 2007 Sep;101(9):1954-60.

15.

Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis.

Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Löfdahl CG.

Respir Res. 2005 Aug 25;6:98.

16.

Airway inflammation contributes to health status in COPD: a cross-sectional study.

Snoeck-Stroband JB, Postma DS, Lapperre TS, Gosman MM, Thiadens HA, Kauffman HF, Sont JK, Jansen DF, Sterk PJ.

Respir Res. 2006 Nov 30;7:140.

17.

Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features.

Bustamante-Fermosel A, De Miguel-Yanes JM, Duffort-Falcó M, Muñoz J.

Am J Emerg Med. 2007 Jun;25(5):515-22.

PMID:
17543654
18.

[Mortality and comorbidity in hospitalized chronic obstructive pulmonary disease patients].

Rubinsztajn R, Chazan R.

Pneumonol Alergol Pol. 2011;79(5):343-6. Polish.

19.

"Obesity paradox" in chronic obstructive pulmonary disease.

Blum A, Simsolo C, Sirchan R, Haiek S.

Isr Med Assoc J. 2011 Nov;13(11):672-5.

20.

Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.

Sobieraj DM, White CM, Coleman CI.

Clin Ther. 2008 Aug;30(8):1416-25. doi: 10.1016/j.clinthera.2008.08.004.

PMID:
18803985
Items per page

Supplemental Content

Support Center